Doi.org/10.1093/rheumatology/kes001
Revision as of 02:33, 18 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == A randomized placebo-controlled trial of methotrexate in psoriatic arthritis; Gabrielle H. Kingsley et l.; Rheumatology; 2012; https://doi.org/10.1093/rheumatology/kes001 == Article providing comments == Comment on: A randomized placebo-controlled trial of methotrexate in psoriatic arthritis: reply; Kingsley, G. H.; Scott, D. L.; ; Rheumatology; 2013-4-1 https://doi.org/10.1093/rheumatology/kes341 == Summary == Note: Opened to append information.")
Target Article[edit | edit source]
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis; Gabrielle H. Kingsley et l.; Rheumatology; 2012; https://doi.org/10.1093/rheumatology/kes001
Article providing comments[edit | edit source]
Comment on: A randomized placebo-controlled trial of methotrexate in psoriatic arthritis: reply; Kingsley, G. H.; Scott, D. L.; ; Rheumatology; 2013-4-1 https://doi.org/10.1093/rheumatology/kes341
Summary[edit | edit source]
Note: Opened to append information.